Mikołaj D.
- Country
- Poland
- Department
- Klinika Pediatrii, Żywienia i Chorób Metabolicznych
Research Overview
Data & Insights
Has run more than one trial at 0 of 16 partner sites.
Specializations
Pediatric Inflammatory Bowel Diseases
The investigator focuses on the management of ulcerative colitis and Crohn’s disease in children and adolescents, addressing disease activity, remission induction, and long‑term outcomes.
- Moderately to severely active ulcerative colitis
- Complex perianal fistulas in Crohn’s disease
- Chronic pouchitis
- Therapeutic strategies for pediatric IBD
Research integrates biologic and small‑molecule therapies to improve pediatric gastrointestinal health.
Rare Metabolic and Genetic Liver Disorders
His work includes rare hepatic conditions such as biliary atresia, Niemann‑Pick disease type C, and other lysosomal storage diseases, emphasizing disease‑modifying interventions.
- biliary atresia post‑Kasai outcomes
- Niemann‑Pick disease type C severity assessment
- cholestatic pruritus management
- metabolic liver disease biomarkers
Efforts aim to enhance survival and quality of life for children with ultra‑rare liver pathologies.
Neurological and Neurodevelopmental Disorders
He investigates conditions affecting the developing nervous system, including tuberous sclerosis complex, focal cortical dysplasia, and pediatric multiple sclerosis.
- seizure control in tuberous sclerosis complex
- GRIN‑related neurodevelopmental disorder therapies
- relapsing‑remitting multiple sclerosis in children
- neurogenic detrusor overactivity management
Studies target disease‑specific pathways to mitigate neurological impairment.
Pediatric Renal and Pulmonary Vascular Diseases
His portfolio addresses kidney and lung vascular disorders such as autosomal recessive polycystic kidney disease and pulmonary arterial hypertension in the pediatric population.
- Chronic kidney disease and proteinuria treatment
- ARPKD progression and renal replacement therapy
- PAH disease‑modifying therapy in children
- Renal outcomes in metabolic disease cohorts
Research aims to preserve organ function and reduce morbidity in affected youths.
Pediatric Endocrine and Growth Disorders
He contributes to the understanding of endocrine conditions including type 1 diabetes mellitus, growth hormone deficiency, and childhood obesity.
- Preservation of beta‑cell function in new‑onset type 1 diabetes
- Growth hormone therapy efficacy in children
- Obesity management strategies in pediatric patients
- Metabolic disease screening and intervention
Efforts focus on optimizing metabolic control and promoting normal growth trajectories.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.